St George's, University Of London

This study tested whether a drug called Lokelma (SZC) can help people with both chronic kidney disease and heart failure safely reach higher doses of standard heart medications (RAAS inhibitors) that are often limited by high potassium levels. 112 adults with stable kidney diseas…